The Impact of Exercise on Sleep in People with Rheumatoid Arthritis: A Pilot Randomised Controlled Trial Dr Sean G. McKenna, PhD, BSc, MBA – University of Limerick
9:00 AM – 11:00 AM ET
Understanding the Rheumatologist-Patient Relationship in Treating Rheumatoid Arthritis Beth Schneider, BA – MyHealthTeams
9:00 AM – 11:00 AM ET
Filgotinib Significantly Improved Patient-reported Health-related Quality of Life for Patients with Active Rheumatoid Arthritis: A Post Hoc Analysis of SF-36 and HAQ-DI from Phase 3 Studies Clifton O. Bingham, III, MD – Johns Hopkins University
9:00 AM – 11:00 AM ET
PROMIS-29 Scores Are Significantly Higher in Patients with Rheumatoid Arthritis Who Meet Criteria for Co-morbid Fibromyalgia (FM) Than in Those with Rheumatoid Arthritis and No FM Kathryn Gibson – Liverpool Hospital
9:00 AM – 11:00 AM ET
Alignment and Discordances in Treatment Perceptions and Shared Decision-Making Among RA Patients and Rheumatology Care Teams ROBERT W. LEVIN, MD – Robert W Levin MD PA
9:00 AM – 11:00 AM ET
Routine Assessment of Patient Index Data (RAPID) 3 as a Predictor of Weight Reduction in Rheumatology Patients Undergoing Bariatric Surgery John Byun, MD – Rush University
9:00 AM – 11:00 AM ET
Meaningful Within-Patient Change in WOMAC Domains in Patients with Moderate-To- Severe Osteoarthritis Philip Conaghan, MD, PhD – University of Leeds
9:00 AM – 11:00 AM ET
Filgotinib Improved Work Productivity and Activity Impairment in Patients with Rheumatoid Arthritis and Inadequate Response to Methotrexate: Results from FINCH-1 Study ZOBAIR M. YOUNOSSI, MD – Betty and Guy Beatty Center for Integrated Research, Inova Health System
9:00 AM – 11:00 AM ET
Filgotinib Improved Work Productivity and Activity Impairment in Patients with Rheumatoid Arthritis and Inadequate Response to Biologic DMARDs: Results from the FINCH 2 Study ZOBAIR M. YOUNOSSI, MD – Betty and Guy Beatty Center for Integrated Research, Inova Health System
9:00 AM – 11:00 AM ET
Filgotinib Improved Work Productivity and Activity Impairment in Patients with Rheumatoid Arthritis Who Are Methotrexate-naïve: Results from the FINCH-3 Study ZOBAIR M. YOUNOSSI, MD – Betty and Guy Beatty Center for Integrated Research, Inova Health System
9:00 AM – 11:00 AM ET
Age, Income, Education, and Health Conditions Are Associated with Patient Empowerment Among US Adults with Arthritis, but Race and Geography Are Not Kathleen Carluzzo, MS – Dartmouth College
9:00 AM – 11:00 AM ET
Treat-to-Target in Rheumatoid Arthritis: Rates of Treatment Changes in Patients Engaged with Care Management Services Compared to Historically Reported National Registry Based Estimates Michele Hamburger, MA – Frances Hamburger Institute
9:00 AM – 11:00 AM ET
Patients’ Perceptions and Expectations Towards the Role of Rheumatologists in the Recommendations of Physical Activity’s Practice - A Cross-sectional Study Involving 308 Patients Living with Rheumatoid Arthritis in France Anne-Christine Rat – Caen Normandie university, CHU Caen
9:00 AM – 11:00 AM ET
The Interpretation of Patient-reported Outcomes in Rheumatoid Arthritis: Do Clinical Trials Adequately Evaluate Meaningful Improvements for Patients? Peter C. Taylor, MD, PhD, MA – University of Oxford
9:00 AM – 11:00 AM ET
Perspectives on Treatment Burden for Methotrexate and TNF-inhibitors Among Psoriatic Arthritis and Rheumatoid Arthritis Patients: A Qualitative Study Alexis Ogdie, MD, MSCE – University of Pennsylvania
9:00 AM – 11:00 AM ET
How Stable Are Medication Necessity Beliefs and Safety Concerns in the First Year of RA? Viviane Ta, MSc – McGill University
9:00 AM – 11:00 AM ET
The Preparation Experience for Total Knee Arthroplasty of Patients with Osteoarthritis: A Cross-Sectional Survey Aretina Leung, BA – Weill Cornell Medicine
9:00 AM – 11:00 AM ET
More Than Half of Newly Diagnosed RA Patients Are Not Convinced of the Necessity of RA Medicines: Associations with RA Characteristics, Symptoms, and Function in the Canadian Early Arthritis Cohort (CATCH) Viviane Ta, MSc – McGill University
9:00 AM – 11:00 AM ET
Veterans with RA and Gout Identify Their Goals and How They Can Work with Clinicians to Achieve Their Goals Swathi Reddy, MD – UT Southwestern Medical Center / Dallas VA Medical Center
9:00 AM – 11:00 AM ET
Counseling on Safe Driving Strategies in Patients with Osteoarthritis and Rheumatoid Arthritis Anna Falls, DO – OhioHealth Riverside Methodist Hospital
9:00 AM – 11:00 AM ET
Treatment Decision Making Among Axial Spondyloarthritis Patients: Real-World Data from the ArthritisPower Registry William B. Nowell, PhD, MSW – Global Healthy Living Foundation
9:00 AM – 11:00 AM ET
Changes in Patient-Reported Outcome (PRO) Scores for Nausea and Fatigue Following Weekly Methotrexate Dose in a Real-World Sample of RA and PsA Patients in the ArthritisPower Registry William B. Nowell, PhD, MSW – Global Healthy Living Foundation
9:00 AM – 11:00 AM ET
The Role of Biological Treatment in the Health-Related Quality of Life of Ankylosing Spondylitis Patients’ Assessment - Meta-Analysis Mariusz Chabowski
9:00 AM – 11:00 AM ET
Relationships Between Disease Patterns in RA and Rheumatology Treatment Kelly O'Neill, BA – Rheumatoid Patient Foundation, Inc.
9:00 AM – 11:00 AM ET
Patient-Reported Data Show the Impact of Time to Diagnosis in RA Kelly O'Neill, BA – Rheumatoid Patient Foundation, Inc.
9:00 AM – 11:00 AM ET
Patient-Reported Outcomes Differentiate Between Remission and Low Disease Activity in Psoriatic Arthritis Juliette Yedimenko, MD – Cleveland Clinic
9:00 AM – 11:00 AM ET
Use of PROMIS29 Across Inflammatory Arthritis: Score Distributions and Impact of Contextual Factors Alexis Ogdie, MD, MSCE – University of Pennsylvania
9:00 AM – 11:00 AM ET
Validation of Patient-reported Outcomes (PRO) Lung Questionnaires for Systemic Juvenile Idiopathic Arthritis (SJIA) Patients at Risk for Lung Disease Kim Nguyen, MD – VA Cincinnati
9:00 AM – 11:00 AM ET
Identifying Sleep Problems in Systemic Juvenile Idiopathic Arthritis (SJIA) Patients with Patient-reported Outcomes (PRO) Questionnaires Kim Nguyen, MD – VA Cincinnati
9:00 AM – 11:00 AM ET
Cost of Non-Persistence in the Treatment with Subcutaneous Tumor Necrosis Factor-Alpha Inhibitors of Inflammatory Arthritis: A Propensity Score Matching Approach Johan Dalén, MSc – ICON plc
9:00 AM – 11:00 AM ET
What’s in a Name? Patient and Family Perspectives on the Naming of Systemic Juvenile Idiopathic Arthritis Rashmi Sinha, PhD – Systemic JIA Foundation
9:00 AM – 11:00 AM ET
WITHDRAWN
9:00 AM – 11:00 AM ET
Prevalence and Impact of Unacceptable Symptom State Among Patients with Psoriatic Arthritis: Results from the National Psoriasis Foundation’s 2019 Annual Survey Alexis Ogdie, MD, MSCE – University of Pennsylvania
9:00 AM – 11:00 AM ET
Rheumatoid Arthritis Patient Phenotypes from a Digital Health Coaching Engagement Program Matt Allison, -None- – Pack Health
9:00 AM – 11:00 AM ET
Impact of Adalimumab (Humira) Therapy on Ocular Inflammation, Selected Health Care Resource Utilization, and Patient-Reported Outcomes in Patients with Active Non-infectious Intermediate, Posterior, or Panuveitis in Routine Clinical Practice Uwe Pleyer – Charite
9:00 AM – 11:00 AM ET
Utilizing Design Thinking to Develop a Decision Aid for Patients with Psoriasis and Psoriatic Arthritis Alexis Ogdie, MD, MSCE – University of Pennsylvania
9:00 AM – 11:00 AM ET
Early Arthritis Global Assesment: What Differences Exist Between Patients and Physicians? Cristina Valero, MD – Hospital de la Princesa, Madrid
